The FDA announced on Aug. 13, 2015, that Qualitest Pharmaceuticals recalled Ampicillin Capsules USP, 250 mg, due to incorrect or missing package inserts containing unapproved labeling. The agency classified the Class III recall as voluntary and initiated by the firm.
How to tell if you have it
- Brand: Qualitest Pharmaceuticals
- Product: Ampicillin Capsules 250 mg
- NDC: 67253-180-50
- Lot #: 52217
- Expiry: 04/18
- Quantity: 360 bottles
The hazard
The product is labeled with unapproved labeling because the package insert is incorrect or missing. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals has 11 other recalls on record since July 6, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026), Dabur Circle K Antibiotic Ointment Recall (June 2, 2026) and Dabur Lil Drug Store Antibiotic Ointment Recall (June 2, 2026).